| 【Company Research】Bilibili (BILI US) – Prioritizing profitability and quality user growth |
| 【Sector Research】China Auto Sector – May NEV likely to hit second highest in history |
| 【Company Research】JOYY Inc. (YY US) – 2H23E recovery in sight |
| 【Company Research】Recbio (2179 HK) – Clinical development of core pipeline products continues |
| 【公司研究】迈瑞医疗 (300760 CH) – 打造智能生态，剑指世界一流 |
| 【Company Research】Weibo (WB US) – Solid margin and attractive valuation; wait for top-line recovery |
| 【Company Research】Meituan (3690 HK) – Determined to maintain local consumer services industry consumer mind share |
| 【Company Research】NetEase (NTES US) – Solid mobile games and margin improvement support strong 1Q23 results |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – To further expand mRNA and ADC pipelines |
| 【Sector Research】China Auto Sector – Mixed picture ahead as inventory risk lingers |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
